Minor
RESOLVE · Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Trial sites expanded: 14 → 20 locations
Alpha Cognition, IncPhase 4 NCT07633470 Registry history of NCT07633470 on ClinicalTrials.gov (opens the registry)